Aeolus files international patent application for new patent on AEOL 10150

摘要

On 3 Dec 2014, Aeolus Pharmaceuticals Inc, a biotechnology company developing compounds to protect against radiological and chemical threats with significant funding from the US Government, announced that it has filed an international patent application under the Patent Cooperation Treaty (PCT) with the US Receiving Office (US/RO) thereby preserving the right to seek patent protection in all PCT contracting countries for new patents covering new inventions resulting . from research and development on its lead compound, broad-spectrum catalytic antioxidant AEOL 10150.